Evidence map›Paper›PMID 38087063›Full record

ArticleEuropean radiology2024

Optic nerve thickening on high-spatial-resolution MRI predicts early-stage postlaminar optic nerve invasion in retinoblastoma.

Christiaan M de Bloeme, Robin W Jansen, Sophia Göricke, Steven T L Grauwels, Sabien van Elst, Petra Ketteler, Hervé J Brisse, Paolo Galluzzi, Liesbeth Cardoen, Selma Sirin and 7 more

Open access · greenAbstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in European radiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 8 institutions in 5 countries.

Christiaan M de BloemeEuropean Retinoblastoma Imaging Collaboration (ERIC), Amsterdam, The Netherlands. c.debloeme@amsterdamumc.nl.ORCID http://orcid.org/0000-0002-4901-0301
Robin W JansenEuropean Retinoblastoma Imaging Collaboration (ERIC), Amsterdam, The Netherlands.
Sophia GörickeEuropean Retinoblastoma Imaging Collaboration (ERIC), Amsterdam, The Netherlands.
Steven T L GrauwelsDepartment of Radiology and Nuclear Medicine, Amsterdam UMC Location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Sabien van ElstEuropean Retinoblastoma Imaging Collaboration (ERIC), Amsterdam, The Netherlands.
Petra KettelerDepartment of Pediatric Oncology, University Hospital Essen, Essen, Germany.
Hervé J BrisseEuropean Retinoblastoma Imaging Collaboration (ERIC), Amsterdam, The Netherlands.
Paolo GalluzziEuropean Retinoblastoma Imaging Collaboration (ERIC), Amsterdam, The Netherlands.
Liesbeth CardoenEuropean Retinoblastoma Imaging Collaboration (ERIC), Amsterdam, The Netherlands.
Selma SirinEuropean Retinoblastoma Imaging Collaboration (ERIC), Amsterdam, The Netherlands.
Mériam KoobEuropean Retinoblastoma Imaging Collaboration (ERIC), Amsterdam, The Netherlands.
Philippe MaederEuropean Retinoblastoma Imaging Collaboration (ERIC), Amsterdam, The Netherlands.
Paul van der ValkDepartment of Pathology, Amsterdam UMC Location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Annette C MollCancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands.
Pim de GraafEuropean Retinoblastoma Imaging Collaboration (ERIC), Amsterdam, The Netherlands.
Marcus C de JongEuropean Retinoblastoma Imaging Collaboration (ERIC), Amsterdam, The Netherlands.
European Retinoblastoma Imaging Collaboration
Dutch Cancer Society · NLAmsterdam University Medical Centers · NLEssen University Hospital · DEInstitut Curie · FRUniversity Hospital of Lausanne · CHEuropean Organisation for Research and Treatment of Cancer · NLUniversity Children's Hospital Zurich · CHUniversity of Siena · IT

Funding

Hanarth Fonds MRI-based Deep Learning SegmentationHanarth Fonds Quantitative Radiomics in Retinoblastoma: A Next Step Towards Personalized Interventions
6 · The paper itself

Abstract

objectivesTo assess the diagnostic accuracy of nerve thickening on MRI to predict early-stage postlaminar optic nerve invasion (PLONI) in retinoblastoma. Furthermore, this study aimed to incorporate measurements into a multiparametric model for radiological determination of PLONI.

methodsIn this retrospective multicenter case-control study, high-spatial-resolution 3D T2-weighted MR images were used to measure the distal optic nerve. Histopathology was the reference standard for PLONI. Two neuroradiologists independently measured the optic nerve width, height, and surface at 0, 3, and 5 mm from the most distal part of the optic nerve. Subsequently, PLONI was scored on contrast-enhanced T1-weighted and 3D T2-weighted images, blinded for clinical data. Optic nerve measurements with the highest diagnostic accuracy for PLONI were incorporated into a prediction model for radiological determination of PLONI.

resultsOne hundred twenty-four retinoblastoma patients (median age, 22 months [range, 0-113], 58 female) were included, resulting in 25 retinoblastoma eyes with histopathologically proven PLONI and 206 without PLONI. ROC analysis of axial optic nerve width measured at 0 mm yielded the best area under the curve of 0.88 (95% confidence interval: 0.79, 0.96; p < 0.001). The optimal width cutoff was ≥ 2.215 mm, with a sensitivity of 84% (95% CI: 64, 95%) and specificity of 83% (95% CI: 75, 89%) for detecting PLONI. Combining width measurements with the suspicion of PLONI on MRI sequences resulted in a prediction model with an improved sensitivity and specificity of respectively up to 88% and 92%.

conclusionPostlaminar optic nerve thickening can predict early-stage postlaminar optic nerve invasion in retinoblastoma. CLINICAL RELEVANCE STATEMENT: This study provides an additional tool for clinicians to help determine postlaminar optic nerve invasion, which is a risk factor for developing metastatic disease in retinoblastoma patients. KEY POINTS: • The diagnostic accuracy of contrast-enhanced MRI for detecting postlaminar optic nerve invasion is limited in retinoblastoma patients. • Optic nerve thickening can predict postlaminar optic nerve invasion. • A prediction model combining MRI features has a high sensitivity and specificity for detecting postlaminar optic nerve invasion.

Indexed as

Magnetic Resonance ImagingNeoplasm InvasivenessOptic NerveRetinal NeoplasmsRetinoblastomaCase-Control StudiesChildChild, PreschoolContrast MediaFemaleHumansImaging, Three-DimensionalInfantInfant, NewbornMaleOptic Nerve NeoplasmsContrast MediaMagnetic resonance imagingOptic nervePediatricsRetinaRetinoblastoma

Identifiers

PMID38087063
OpenAlexW4389640043

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.